July 6, 2017 — Fujifilm Medical Systems U.S.A. Inc. will present its comprehensive portfolio of digital radiography (DR) and mammography solutions at the American Healthcare Radiology Administrators (AHRA) 2017 Annual Meeting, July 9-12 in Anaheim, Calif. Fujifilm’s solutions are designed to optimize workflow and increase the safety and satisfaction of patients.
The company will be exhibiting the following solutions:
- FDR AQRO: The FDR AQRO Mini Mobile System is a complete DR system that delivers high-resolution images and low patient dose in a variety of point-of-care and dedicated use settings, all within an ultra-lightweight mini mobile cart. The system combines Fujifilm’s core dose-saving technologies such as Irradiation Side Sampling (ISS) and noise reduction circuitry, with Virtual Grid and an all New Dynamic Visualization II image processing to produce exceptional images at gentle dose for all patient sizes and anatomy;
- Aspire Cristalle: Fujifilm’s latest advancement in digital mammography includes digital breast tomosynthesis (DBT) and state-of-the-art dose saving, Hexagonal Close Pattern (HCP) image capture technology. The newest solution optimizes contrast, enables low dose and fast acquisition time, all while providing patient comfort with the company’s Comfort Paddle; and
- FDR D-EVO GL: The FDR D-EVO GL is the world's first and only, single-exposure long-length DR detector, according to Fujifilm. With easy patient positioning and rapid acquisition time, it simplifies exams for the technologist while lowering dose and discomfort for the patient. With a 17x49-inch field of view, it can accommodate all patient sizes and help prevent retakes, and when used with Fujifilm’s Virtual Grid, dose can be reduced as much as 50 percent compared to grid exams.
For all AHRA attendees, Fujifilm will host a complimentary breakfast symposium, “Optimizing Breast Cancer Detection, Departmental Efficiencies and the Patient Experience,” on Wednesday, July 12. This educational workshop hosted by Fujifilm Medical System U.S.A.’s Gregg Cretella, director of field sales support and David Wild, director of medical informatics, will explore the newest advances in digital mammography and medical informatics to understand how these tools can maximize financial, operational and clinical outcomes. Additionally, this session will help attendees evaluate the readiness of their current information technology (IT) infrastructure and make sound decisions when considering the purchase of new breast imaging technologies.
For more information: www.fujimed.com
May 17, 2024 
